Key Statistics for COH
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (AUD) (ttm)
|Est. EPS (AUD) (06/2013)
|Est. PEG Ratio
|Market Cap (M AUD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (AUD)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for COH
- Net Income (M/AUD)
Cochlear Limited researches, develops and markets cochlear implant systems for hearing impaired individuals. The Company's hearing implant systems include Nucleus and Baha and are sold both domestically and internationally.
More Company Profile & Key Executives for COH
|Christopher Graham Roberts "Chris"President/CEO||Neville J MitchellCFO/Secretary|
|Richard BrookPres:European||Mark SalmonPres:Asia Pacific|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries